Clear value communication is central to successful market access. I support teams in translating complex clinical and economic evidence into credible value propositions that resonates with payers, HTA bodies, and internal stakeholders.

My work focuses on bringing structure and clarity to situations where the evidence base is strong but the value narrative is not yet fully aligned.

Value proposition development

I help teams articulate the core drivers of value and develop messaging that supports consistent positioning across global and affiliate markets.

Global value dossiers

I write global value dossiers that fully synthesize clinical, economic, and real-world evidence into clear payer-facing narratives. This includes defining the unmet need and burden, positioning comparators, and shaping arguments that anticipate likely HTA challenges.

Payer-facing materials

I develop objection handlers, briefing books, and communication tools that support engagement with HTA agencies, advisory boards, and internal decision-makers.

Narrative alignment

I work with cross-functional teams to ensure that value messaging remains coherent across clinical development, HEOR strategy, pricing assumptions, and local submission planning.

My approach combines analytical rigour with practical delivery. I work closely with global and affiliate teams to understand the current challenges and reimbursement context, identify evidence gaps, and shape narratives that support confident engagement with decision-makers.

Where needed, I support iterative refinement of messaging as assets evolve and new data become available.

If you are developing a global value strategy or preparing key payer communications, I would be happy to discuss how I can support your team.